252 related articles for article (PubMed ID: 34685575)
1. The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome.
Masselli E; Pozzi G; Carubbi C; Vitale M
Cells; 2021 Sep; 10(10):. PubMed ID: 34685575
[TBL] [Abstract][Full Text] [Related]
2. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
Hinds DA; Barnholt KE; Mesa RA; Kiefer AK; Do CB; Eriksson N; Mountain JL; Francke U; Tung JY; Nguyen HM; Zhang H; Gojenola L; Zehnder JL; Gotlib J
Blood; 2016 Aug; 128(8):1121-8. PubMed ID: 27365426
[TBL] [Abstract][Full Text] [Related]
3. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
Rumi E; Cazzola M
Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
[TBL] [Abstract][Full Text] [Related]
5. Familial MPN Predisposition.
Tashi T; Swierczek S; Prchal JT
Curr Hematol Malig Rep; 2017 Oct; 12(5):442-447. PubMed ID: 29027642
[TBL] [Abstract][Full Text] [Related]
6. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
[TBL] [Abstract][Full Text] [Related]
7. Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms.
Braunstein EM; Imada E; Pasca S; Wang S; Chen H; Alba C; Hupalo DN; Wilkerson M; Dalgard CL; Ghannam J; Liu Y; Marchionni L; Moliterno A; Hourigan CS; Gondek LP
Leukemia; 2023 Mar; 37(3):627-635. PubMed ID: 36543879
[TBL] [Abstract][Full Text] [Related]
8. Role of germline genetic factors in MPN pathogenesis.
Harutyunyan AS; Kralovics R
Hematol Oncol Clin North Am; 2012 Oct; 26(5):1037-51. PubMed ID: 23009936
[TBL] [Abstract][Full Text] [Related]
9. Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.
Bao EL; Nandakumar SK; Liao X; Bick AG; Karjalainen J; Tabaka M; Gan OI; Havulinna AS; Kiiskinen TTJ; Lareau CA; de Lapuente Portilla AL; Li B; Emdin C; Codd V; Nelson CP; Walker CJ; Churchhouse C; de la Chapelle A; Klein DE; Nilsson B; Wilson PWF; Cho K; Pyarajan S; Gaziano JM; Samani NJ; ; ; Regev A; Palotie A; Neale BM; Dick JE; Natarajan P; O'Donnell CJ; Daly MJ; Milyavsky M; Kathiresan S; Sankaran VG
Nature; 2020 Oct; 586(7831):769-775. PubMed ID: 33057200
[TBL] [Abstract][Full Text] [Related]
10. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
[TBL] [Abstract][Full Text] [Related]
11. Germline polymorphisms and the risk of therapy-related myeloid neoplasms.
Takahashi K
Best Pract Res Clin Haematol; 2019 Mar; 32(1):24-30. PubMed ID: 30927971
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of mutations in myeloproliferative neoplasms.
Levine RL
Best Pract Res Clin Haematol; 2009 Dec; 22(4):489-94. PubMed ID: 19959098
[TBL] [Abstract][Full Text] [Related]
13. Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.
Masselli E; Pozzi G; Gobbi G; Merighi S; Gessi S; Vitale M; Carubbi C
Cells; 2020 Sep; 9(9):. PubMed ID: 32967342
[TBL] [Abstract][Full Text] [Related]
14. An immune dysregulation in MPN.
Barosi G
Curr Hematol Malig Rep; 2014 Dec; 9(4):331-9. PubMed ID: 25139710
[TBL] [Abstract][Full Text] [Related]
15. Mutations in myeloproliferative neoplasms - their significance and clinical use.
Schischlik F; Kralovics R
Expert Rev Hematol; 2017 Nov; 10(11):961-973. PubMed ID: 28914569
[TBL] [Abstract][Full Text] [Related]
16. [Myeloid neoplasms with germline predisposition].
Yoshida K
Rinsho Ketsueki; 2023; 64(9):949-954. PubMed ID: 37793870
[TBL] [Abstract][Full Text] [Related]
17. Myeloproliferative neoplasm stem cells.
Mead AJ; Mullally A
Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
[TBL] [Abstract][Full Text] [Related]
18. Genomics of Myeloproliferative Neoplasms.
Zoi K; Cross NC
J Clin Oncol; 2017 Mar; 35(9):947-954. PubMed ID: 28297629
[TBL] [Abstract][Full Text] [Related]
19. The
Hong T; Luo M; Liu Q
Genet Test Mol Biomarkers; 2020 Apr; 24(4):181-187. PubMed ID: 32202925
[No Abstract] [Full Text] [Related]
20. Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).
Dunbar A; Nazir A; Levine R
Curr Protoc Pharmacol; 2017 Jun; 77():14.40.1-14.40.19. PubMed ID: 28640953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
